PFE240809P28000
- 0.08
- +0.04+100.00%
Pfizer Newsroom
Pfizer Options Spot-On: On August 5th, 127.78K Contracts Were Traded, With 2.9 Million Open Interest
Pfizer | 10-Q: Quarterly report
Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data
Genmab Stock Slides 7% as BioNTech Ends Acasunlimab Collaboration
Moderna Facing Headwinds for Respiratory Syncytial Virus, COVID Vaccines, RBC Says
Unusual Options Activity: PFE, PAYC and Others Attract Market Bets, PFE V/OI Ratio Reaches 217.6
Trending Industry Today: Altimmune Leads Losses Pre-Market In Weight Loss Drugs Stocks
With 68% Ownership of the Shares, Pfizer Inc. (NYSE:PFE) Is Heavily Dominated by Institutional Owners
BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products
Express News | BioNTech SE - Q2 Revenue at 128.7 Mln EUR
Express News | BioNTech SE - Q2 Net Loss at 807.8 Mln EUR
Express News | BioNTech SE - H1 Revenue at 316.3 Mln EUR
Express News | BioNTech SE - Ended Q2 With EUR 18.5 Bln in Cash, Cash Equivalents and Security Investments
Express News | BioNTech SE - H1 Net Loss at 1.12 Bln EUR
Express News | BioNTech SE - Reiterates Guidance for Total Revenues in the Range of EUR 2.5-3.1 Bln
19 Out of 21 Healthcare Companies Topped Profit Estimates This Week: Earnings Scorecard
Is This Decision by Pfizer Bad News for Eli Lilly?
Intel Shows Dividends Aren't Guaranteed. 12 Stocks That Should Keep Growing Payouts. -- Barrons.com
Pfizer Options Spot-On: On August 2nd, 173.86K Contracts Were Traded, With 2.9 Million Open Interest
Moderna Stock Trading Lower On Dismal Guidance, Analysts Cuts Price Targets Noting Competitive Pressure From GSK, Pfizer